GSK’s vaccine—which targets two primary flu antigens—elicited higher immune responses in both younger and older adults in a mid-stage study. The Phase 3 launch, planned for...
After downsizing by 50% last year, Arsenal Biosciences is again laying off employees. This time, 99 people are getting cut as part of a strategic shift...
Astellas Pharma, BridgeBio, BeOne Medicines and six other large biotechs join the 17 Big Pharmas that previously signed on to President Donald Trump’s Most Favored Nation...
Racura Oncology recently raised AU$34.3 (US$24.31) million to fund its RC220 clinical programmes in acute myeloid leukaemia (AML), epidermal growth factor receptor mutant (EGFRm) non-small cell...
Spatial transcriptomics has given cancer researchers a powerful way to see not only which genes are active in a tumor, but where that activity is taking...
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns
New guidelines on migraine prevention reflect increasing options for patients
Single-Use Comes of Age–What Comes Next?
FDA OKs Takeda, Protagonist drug for rare blood cancer
STAT+: GLP-1 drugs are almost single-handedly forcing employers to reconsider workers’ health care
Scan to Read